drugset / Trial / NCT04041713

A Pilot Study of an Antioxidant Cocktail vs. Placebo in the Treatment of Children and Adolescents With Rett Syndrome

NCT04041713 ↗

RandomizedCrossoverQuadruple-blindTreatment

Summary

This study will examine the potential efficacy and safety of Rett-T for core motor deficits of Rett syndrome, and will explore biological markers of safety and treatment response.

Timeline

Start
2025-10-01
Primary completion
2026-11-30
Completion
2026-11-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Rett-T Unknown 4 g Oral
Comparator Rett-T Unknown 8 g Oral

Indications